News
![Synopsys stock: Unsung hero of the AI revolution: https://www.marketbeat.com/logos/articles/med_20231229073521_synopsys-stock-unsung-hero-of-the-ai-revolution.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBelg5YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6fafaff7c521ba39100a73bf3cadae13645ac976/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231229073521_synopsys-stock-unsung-hero-of-the-ai-revolution.jpg?locale=us)
Synopsys stock: Unsung hero of the AI revolution
Synopsys Inc. (NASDAQ: SNPS), maker of semiconductor design software, created a buzz recently when it offered to buy engineering software maker Ansys Inc. (NASDAQ: ANSS).
Synopsys isn’t a
![Apple stock is institutional favorite, but is it overvalued?: https://www.marketbeat.com/logos/articles/med_20231229072720_apple-stock-is-institutional-favorite-but-is-it-ov.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBemY5YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3ed54ca64d26e9f9b75f8f2a29eb9d03f5765584/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231229072720_apple-stock-is-institutional-favorite-but-is-it-ov.jpg?locale=us)
Apple stock is institutional favorite, but is it overvalued?
With Apple Inc. (NASDAQ: AAPL) holding the No. 1 spot as the biggest S&P 500 component, and having posted a 2023 gain of 49.39% is the stock overvalued, or primed for a correction in 2024?
Even
![Four beaten-down penny stocks ready to take off: https://www.marketbeat.com/logos/articles/med_20231228125201_chart-lazr-12282023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeUw5YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--235d2f6d25f6c1195045857494baccf3be40f8de/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231228125201_chart-lazr-12282023ver001.png?locale=us)
Four beaten-down penny stocks ready to take off
Penny stocks are attractive simply because of the opportunity for exponential returns. Stocks like Alphabet Inc. (NASDAQ: GOOG), Microsoft Corporation (NASDAQ: MSFT) and Apple Inc. (NASDAQ: AAPL)
![Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Massives Kaufsignal. Diese Biotech-Aktie jetzt kaufen nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/73132/AC01-29-23_AC1.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL0g4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d8ff5dcb07839f213b23490f0422598cb927fee3/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC01-29-23_AC1.001.png?locale=us)
Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Massives Kaufsignal. Diese Biotech-Aktie jetzt kaufen nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Kaufsignal. Diese Biotech-Aktie kaufen nach 15.973% mit BioNTech
29.12.23 08:03
London (www.aktiencheck.de, Anzeige)
![If you buy the dogs, should you sell these Dow leaders?: https://www.marketbeat.com/logos/articles/med_20231228074608_chart-intc-12282023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNjc4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--55601b3b18cc9a888edeb36d42a5a1b380583049/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231228074608_chart-intc-12282023ver001.png?locale=us)
If you buy the dogs, should you sell these Dow leaders?
The Dogs of the Dow is a popular strategy getting much attention now that the year-end is here. The theory assumes that this year’s losers will be next year’s winners, which is often true. Dow
![Ray Dalio keeps adding to this ETF, what's he thinking?: https://www.marketbeat.com/logos/articles/med_20231228072323_ray-dalio-keeps-adding-to-this-etf-whats-he-thinki.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXY4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--90be5fd54a0ac7e67a2950b92bfce54c74f46131/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231228072323_ray-dalio-keeps-adding-to-this-etf-whats-he-thinki.jpg?locale=us)
Ray Dalio keeps adding to this ETF, what's he thinking?
Last quarter, it became evident to thousands of investors just like you just how bullish Ray Dalio had become on Asian markets. Still, while most thought it was a one-time allocation to gain the
![2 Tech stocks getting bullish upgrades ahead of Q1: https://www.marketbeat.com/logos/articles/med_20231228073315_2-tech-stocks-getting-bullish-upgrades-ahead-of-q1.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNXI4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e17b42796ac2b21ce345659593b407320e13a3ca/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231228073315_2-tech-stocks-getting-bullish-upgrades-ahead-of-q1.jpg?locale=us)
2 Tech stocks getting bullish upgrades ahead of Q1
There’s no doubt about it: equities have had a super strong end to the year, with the Dow Jones index already at fresh all-time highs and the others on its heels. The benchmark S&P 500 index, for
![What to expect from the Q1 earnings reporting cycle: https://www.marketbeat.com/logos/articles/med_20231227123634_chart-spy-12272023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNGo4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--589c99b6a6dc79191321a53c992de71320cc4e5f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231227123634_chart-spy-12272023ver001.png?locale=us)
What to expect from the Q1 earnings reporting cycle
The New Year is almost upon us and, with it, the next earnings reporting cycle. The calendar Q1/fiscal Q4 cycle is expected to bring another quarter of growth for the S&P 500 (NYSEARCA: SPY) and
![If Ray Dalio took profits here, then this stock needs to catch up: https://www.marketbeat.com/logos/articles/med_20231227200044_if-ray-dalio-took-profits-here-then-this-stock-nee.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMi84YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e4debf313a476e0917712435440ca876e3340820/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231227200044_if-ray-dalio-took-profits-here-then-this-stock-nee.jpg?locale=us)
If Ray Dalio took profits here, then this stock needs to catch up
If there is one thing that investors need help getting used to, it is learning where - and where not - to take cues for potentially better places to invest when they come up. Many "experts" are
![3 tech stocks on the verge of major breakouts: https://www.marketbeat.com/logos/articles/med_20231227192924_3-tech-stocks-on-the-verge-of-major-breakouts.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM0g4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fd4dea907a372f4d5ff42e12c7524468abb63a6b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231227192924_3-tech-stocks-on-the-verge-of-major-breakouts.jpg?locale=us)
3 tech stocks on the verge of major breakouts
As we near the year's end, the technology sector is concluding on an impressive note, having recently reached new all-time highs. The tech sector has taken the lead throughout the year, outpacing
![Eilt: Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. Massives Kaufsignal. Diesen 359% Biotech Hot Stock jetzt kaufen nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.: https://www.irw-press.at/prcom/images/messages/2023/73122/AC12-28-23AC1.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMGI4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--708cb9a5928b8e9d3b2e446ddf1a0902dd017b6d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC12-28-23AC1.001.png?locale=us)
Eilt: Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. Massives Kaufsignal. Diesen 359% Biotech Hot Stock jetzt kaufen nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.
Eilt: Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. 359% Biotech Aktientip nach 134.452% mit Biogen
28.12.23 08:02
London (www.aktiencheck.de, Anzeige)
![Are high-yield Dow Dogs a good buy for 2024?: https://www.marketbeat.com/logos/articles/med_20231227102631_chart-vz-12272023-002ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdzc4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--87ec8bda9285b5e3b321b3b7727ce0b37f56389c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231227102631_chart-vz-12272023-002ver001.png?locale=us)
Are high-yield Dow Dogs a good buy for 2024?
The Dogs of the Dow theory assumes that this year’s worst performers will be the best-performing stocks in the next. If not, they should provide solid rebounds due to their “lower” value, and many
![Synopsys offers to acquire Ansys, sparks stock surge: https://www.marketbeat.com/logos/articles/med_20231227101520_synopsys-offers-to-acquire-ansys-sparks-stock-surg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdy84YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--a4de497fcdd2a732a4254e8a90a018e9f127b581/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231227101520_synopsys-offers-to-acquire-ansys-sparks-stock-surg.jpg?locale=us)
Synopsys offers to acquire Ansys, sparks stock surge
Shareholders of engineering simulation software maker Ansys Inc. (NASDAQ: ANSS) got a holiday gift as the stock rallied more than 18% on December 22 on news that Synopsys Inc. (NASDAQ: SNPS) was
![Buffett keeps buying Occidental Petroleum, should you?: https://www.marketbeat.com/logos/articles/med_20231227091215_chart-oxy-12272023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd2I4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f716f9ea15d25e2b9deca0f2e358e4e43416aed6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231227091215_chart-oxy-12272023ver001.png?locale=us)
Buffett keeps buying Occidental Petroleum, should you?
The price action in Occidental Petroleum (NYSE: OXY) has been range-bound for the last two years and may not break out of the range soon. However, the stock retreated to the low end of the range
![The most upgraded stocks from 2023: buy, sell or hold?: https://www.marketbeat.com/logos/articles/med_20231227081454_chart-crm-12272023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd2Y4YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--244ebc1d0bdb6129914f587deb4afbd6b77ba8e1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231227081454_chart-crm-12272023ver001.png?locale=us)
The most upgraded stocks from 2023: buy, sell or hold?
2023 was a busy year for the analysts; their activity has helped to lift the S&P 500 (NYSEARCA: SPY) 25% for the year and may help drive it to new highs in 2025. The most upgraded stocks for the
![T-Mobile is suddenly the industry gem with analyst target boosts: https://www.marketbeat.com/logos/articles/med_20231227075346_t-mobile-is-suddenly-the-industry-gem-with-analyst.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBKzM3YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--104490e41bed9c660e685ffd593073ba34ee59d9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231227075346_t-mobile-is-suddenly-the-industry-gem-with-analyst.jpg?locale=us)
T-Mobile is suddenly the industry gem with analyst target boosts
There are always stocks that feel very cold to the touch, especially shivering to those who cannot afford to buy thousands of shares to make every uptick count. Companies in the technology sector
![Eilt: Hautkrebs vollständig geheilt - Massives Kaufsignal. Diesen 359% Biotech Hot Stock jetzt kaufen nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/73117/AC12-27-23_ac1.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNW43YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e77f9c81b3810f3c4c0a543b80ec5c39e0c501e3/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC12-27-23_ac1.001.png?locale=us)
Eilt: Hautkrebs vollständig geheilt - Massives Kaufsignal. Diesen 359% Biotech Hot Stock jetzt kaufen nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Massives Kaufsignal. Neuer 359% Biotech Aktientip nach 15973% mit BioNTech ($BNTX)
27.12.23 08:02
London (www.aktiencheck.de, Anzeige)
![Align Technology: Protected by more factors than any other stock: https://www.marketbeat.com/logos/articles/med_20231226071503_align-technology-protected-by-more-factors-than-an.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDM3YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fa1ae640f2c06b2912e0858a5f4f13c96dc64e30/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231226071503_align-technology-protected-by-more-factors-than-an.jpg?locale=us)
Align Technology: Protected by more factors than any other stock
Because the past few months in the stock market have been a wild emotional roller coaster, most investors are now looking for the most logical and fundamental reasons to justify investing in any
![XLF's stellar year-end run: key insights & top performers: https://www.marketbeat.com/logos/articles/med_20231226070512_xlfs-stellar-year-end-run-key-insights-top-perform.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMUQ3YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d9e9942eee5f459d92a48cf351f3286975ea82cd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231226070512_xlfs-stellar-year-end-run-key-insights-top-perform.jpg?locale=us)
XLF's stellar year-end run: key insights & top performers
The financial sector and popular sector ETF Financial Select Sector Fund (NYSE: XLF) has enjoyed a stellar end to the year. A quick glance at the XLF’s daily chart almost makes it appear like the
![Intel ups the ante in the AI chip arena against Nvidia: https://www.marketbeat.com/logos/articles/med_20231224105734_chart-intc2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMC83YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7ab3f06bae12dedbc80a981ba8da2221686052f4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231224105734_chart-intc2.jpg?locale=us)
Intel ups the ante in the AI chip arena against Nvidia
While the artificial intelligence (AI) computing market has been dominated by Nvidia Co. (NASDAQ: NVDA), new challengers are invading their turf with their own AI accelerators. 2024 should prove
![Zillow is the stock to show you the new homes Buffett just bet on: https://www.marketbeat.com/logos/articles/med_20231225182640_zillow-is-the-stock-to-show-you-the-new-homes-buff.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMEw3YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e72871da7794bb726327bfd9c71c23ab5d03b5df/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231225182640_zillow-is-the-stock-to-show-you-the-new-homes-buff.jpg?locale=us)
Zillow is the stock to show you the new homes Buffett just bet on
Industries that have stood the test of time are typically very reliable and provide an extended track record of success; what most people (and investors) need to prepare for is an inevitable wave
![It's here: Netflix's rally is now set by analysts and Ray Dalio: https://www.marketbeat.com/logos/articles/med_20231225182858_its-here-netflixs-rally-is-now-set-by-analysts-and.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMFA3YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--f35d4f9ec10ef4b33bac1c3d22f15d2c4ee53161/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231225182858_its-here-netflixs-rally-is-now-set-by-analysts-and.jpg?locale=us)
It's here: Netflix's rally is now set by analysts and Ray Dalio
Most investors can only dream of matching even 1.0% of a successful investment track record like Ray Dalio's. His hedge fund, Bridgewater Associates, is the largest one in the world, and they have
![What is the 'Magnificent Seven', and how to gain exposure?: https://www.marketbeat.com/logos/articles/med_20231222071709_what-is-the-magnificent-seven-and-how-to-gain-expo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzc1YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--29f757d841be4d68a3fd203e9cd879437138a54e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231222071709_what-is-the-magnificent-seven-and-how-to-gain-expo.jpg?locale=us)
What is the 'Magnificent Seven', and how to gain exposure?
Move over FAANG, there’s a new and improved basket of stocks leading the way: The ‘Magnificent Seven.’
Earlier this year, Bank of America's Michael Hartnett dubbed a group of top stocks the
![Nike’s miss could be our opportunity: https://www.marketbeat.com/logos/articles/med_20231222071331_nikes-miss-could-be-our-opportunity.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLy81YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--aa4752b8a614e69e59436160a4542402df311ee5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231222071331_nikes-miss-could-be-our-opportunity.jpg?locale=us)
Nike’s miss could be our opportunity
The big swoosh is set to look a little deflated heading into 2024 after Nike Inc (NYSE: NKE) reported its fiscal Q2 earnings last night. Shares had been rallying since the end of September
![Why Micron’s 2024 could be its best year ever: https://www.marketbeat.com/logos/articles/med_20231221075125_why-microns-2024-could-be-its-best-year-ever.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdy81YXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--4355e72513e6367665dc284e232687909f4995a9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20231221075125_why-microns-2024-could-be-its-best-year-ever.jpg?locale=us)
Why Micron’s 2024 could be its best year ever
With just a few days left until Santa comes, shares of Micron Technology Inc (NASDAQ: MU) are set to give investors an early Christmas present. They jumped 5% in last night’s after-hours sessions